rs16823424

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_001348800.3(ZBTB20):​c.-456+996G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0502 in 152,040 control chromosomes in the GnomAD database, including 645 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.050 ( 645 hom., cov: 32)

Consequence

ZBTB20
NM_001348800.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0730

Publications

0 publications found
Variant links:
Genes affected
ZBTB20 (HGNC:13503): (zinc finger and BTB domain containing 20) This gene, which was initially designated as dendritic cell-derived BTB/POZ zinc finger (DPZF), belongs to a family of transcription factors with an N-terminal BTB/POZ domain and a C-terminal DNA-bindng zinc finger domain. The BTB/POZ domain is a hydrophobic region of approximately 120 aa which mediates association with other BTB/POZ domain-containing proteins. This gene acts as a transcriptional repressor and plays a role in many processes including neurogenesis, glucose homeostasis, and postnatal growth. Mutations in this gene have been associated with Primrose syndrome as well as the 3q13.31 microdeletion syndrome. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Feb 2017]
ZBTB20 Gene-Disease associations (from GenCC):
  • Primrose syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • diabetes mellitus
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001348800.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001348800.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
NM_001348800.3
MANE Select
c.-456+996G>A
intron
N/ANP_001335729.1Q9HC78-1
ZBTB20
NM_001348803.3
c.-579+996G>A
intron
N/ANP_001335732.1Q9HC78-1
ZBTB20
NM_001164343.2
c.-615+996G>A
intron
N/ANP_001157815.1Q9HC78-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ZBTB20
ENST00000675478.1
MANE Select
c.-456+996G>A
intron
N/AENSP00000501561.1Q9HC78-1
ZBTB20
ENST00000474710.6
TSL:1
c.-636+996G>A
intron
N/AENSP00000419153.1Q9HC78-1
ZBTB20
ENST00000357258.8
TSL:1
c.-511+996G>A
intron
N/AENSP00000349803.3Q9HC78-2

Frequencies

GnomAD3 genomes
AF:
0.0501
AC:
7604
AN:
151922
Hom.:
640
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.173
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0173
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.0110
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.000485
Gnomad OTH
AF:
0.0327
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0502
AC:
7626
AN:
152040
Hom.:
645
Cov.:
32
AF XY:
0.0490
AC XY:
3643
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.173
AC:
7182
AN:
41470
American (AMR)
AF:
0.0172
AC:
263
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3468
East Asian (EAS)
AF:
0.0110
AC:
57
AN:
5184
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10564
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.000485
AC:
33
AN:
67972
Other (OTH)
AF:
0.0323
AC:
68
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
333
666
999
1332
1665
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0572
Hom.:
438
Bravo
AF:
0.0574
Asia WGS
AF:
0.0120
AC:
41
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
16
DANN
Benign
0.74
PhyloP100
0.073
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs16823424;
hg19: chr3-114692217;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.